Promoting and facilitating strategies to improve cardiovascular health worldwide
-
Conferences & Events
Organising high level conferences featuring presentations, seminars and discussions and attended by world-renowned consultants.
-
Webinars & e‑Learning
Specific training and best-practice modules, including ISCP on-demand webinars and ISCP-endorsed webinars
-
Expert Reviews & Analysis
Expert Reviews, Opinions and Brief Reports. Independent summary information to keep you up to date with the latest research.
-
Drug Interaction Database
A reference tool for cardiovascular physicians and surgeons, pharmacists, pharmacologists, scientists and medical practitioners.
Save the Date!
2025 General Assembly
Dear ISCP Member,
It is with great pleasure that we invite you to the ISCP General Assembly 2025, which will take place online on Wednesday, May 7, 2025, at 12:00 BST. This annual gathering is a key moment for our society, providing an opportunity to review the past year, discuss future plans, and make important decisions together.
The link to the Zoom meeting will be shared closer to the date. If the date approached and you haven´t received it please email Lourdes Marenco lourdesmarenco@iscpcardio.org
We strongly encourage all paying members to attend, as your participation is vital to the continued success of our society. Should you have any questions or topics you wish to raise during the Assembly, please feel free to reach out in advance.
We look forward to your presence and valuable contributions.
A-Z of CV Pharmacotherapy:
ISCP Webinar Series
The latest additions to our A to Z of CV Pharmacotherapy programme are available to view in the Webinars On Demand section:
6- Managing Iron Deficiency in Heart Failure: Practical Considerations
5-Anticoagulation Stewardship – Let´s start a Global Revolution
4- Treating Cardiometabolic Syndromes – What’s The Best Approach?
3- Decongesting the current diuretic landscape in Heart Failure
2- Digitalising Care for Hypertension: One for All, All for One
1- Statin’ the source of that pain: Pharmacogenomics As A Preemptive Tool
Details of future webinars are available in Upcoming webinars , including the next series of our own A to Z of CV Pharmacotherapy programme
Have you watched one or more of the above sessions? We value your opinion. Take 3 minutes to give us feedback on the series.
Upcoming Events
7
May
ISCP GENERAL ASSEMBLY 2025
Annual Meeting 07 May 2025
14
May
29
Aug
ESC 2025 MADRID
Conferences 29 Aug 2025
25
Sep
ISCP 2025 SPAIN
Annual Meeting, Conferences 25 Sep 2025
Highlights
The latest reviews, resources and expert analysis from our website.
newsfeed
Two agents targeting ANGPTL3 successful at lowering lipids in phase 2 trials
Posted on April 25, 2025
CHICAGO — Two novel agents targeting angiopoietin-like protein 3 demonstrated safety and lipid-lowering capabilities in phase 2 trials, according to findings presented... more
Tired of pleasing ‘corporate masters,’ physician union membership rises
Posted on April 25, 2025
Union membership among health care professionals in the United States, including physicians, is on the rise, which could have seismic implications in... more
Improving, maintaining Life’s Essential 8 early lowers CVD risk at midlife
Posted on April 24, 2025
Higher cumulative heart health score from age 18 to 45 years was associated with lower risk for cardiovascular disease and death at... more
Sudden cardiac arrest survival rates up for young athletes, but racial disparities exist
Posted on April 23, 2025
CHICAGO — Survival from sudden cardiac arrest has improved in young competitive athletes in recent years, but racial disparities in outcomes were... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
-
Alberto Lorenzatti
President
Dr. Alberto J. Lorenzatti is currently the Co-Director of the DAMIC Medical Institute / Rusculleda Foundation for Research, Teaching and Patient Care (Head of the Clinical Research network with more than 30 research sites in Argentina) and he was the Chief of Cardiology at the Cordoba Hospital, Cordoba, Argentina... more
-
Thomas Kahan
Past President
Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more
-
Sang Hong Baek
Board Member
Sang Hong Baek is a Board Member of ISCP and also Governor for the Republic of Korea. ISCP Governors act as representatives for different countries worldwide to encourage local participation and contribute to the ISCP's educational programmes. Past president of the ISCP Professor Sang Hong Baek is Director of Heart... more
-
Pablo Avanzas
Secretary
Professor Pablo Avanzas is Director of Invasive Cardiology at Hospital Universitario Central de Asturias and Full Professor of Cardiology at University of Oviedo in Asturias, Spain. Affiliations/Memberships • Full Professor of Cardiology, University of Oviedo, Oviedo, Spain. • Director of Invasive Cardiology at Hospital Universitario Central de Asturias, Oviedo,... more
